| Literature DB >> 34965433 |
Sean W Wallace1, Malcolm C Lizzappi1, Elif Magemizoğlu1, Hong Hur2, Yupu Liang2, Shai Shaham3.
Abstract
Animals encounter microorganisms in their habitats, adapting physiology and behavior accordingly. The nematode Caenorhabditis elegans is found in microbe-rich environments; however, its responses to fungi are not extensively studied. Here, we describe interactions of C. elegans and Penicillium brevicompactum, an ecologically relevant mold. Transcriptome studies reveal that co-culture upregulates stress response genes, including xenobiotic-metabolizing enzymes (XMEs), in C. elegans intestine and AMsh glial cells. The nuclear hormone receptors (NHRs) NHR-45 and NHR-156 are induction regulators, and mutants that cannot induce XMEs in the intestine when exposed to P. brevicompactum experience mitochondrial stress and exhibit developmental defects. Different C. elegans wild isolates harbor sequence polymorphisms in nhr-156, resulting in phenotypic diversity in AMsh glia responses to microbe exposure. We propose that P. brevicompactum mitochondria-targeting mycotoxins are deactivated by intestinal detoxification, allowing tolerance to moldy environments. Our studies support the idea that C. elegans NHRs may be regulated by environmental cues.Entities:
Keywords: C. elegans; P. brevicompactum; fungus; glia; intestine; nhr-156; nhr-45; xenobiotic metabolizing
Mesh:
Substances:
Year: 2021 PMID: 34965433 PMCID: PMC8733895 DOI: 10.1016/j.celrep.2021.110166
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423
Figure 1.Penicillium brevicompactum induces expression of stress response genes including xenobiotic-metabolizing enzymes in C. elegans
(A) Classification of P. brevicompactum-dependent genes.
(B) Statistically enriched gene categories. (A) and (B) Based on analysis using WormCat (Holdorf et al., 2019).
(C) Heatmap of xenobiotic-metabolizing enzymes (XMEs) induced by P. brevicompactum.
(D) Summary of confirmed P. brevicompactum-induced genes. +++ strong expression; ++ moderate expression; + weak expression. Tissues classified as other are as follows: cyp-33C2, excretory cell, vulva, several undefined cells in the head and tail; cyp-14A4, pharynx; gst-33, excretory cell, pharynx, several undefined cells in the head and tail.
(E) Expression of cyp-33C2∷GFP with F16F9.3p∷dsRed (AMsh glia) and elt-2p∷mCherry (intestine).
(F–J) expression of additional XMEs listed in (D). mir-228p∷NLS-RFP is pan-glial. Open arrowhead, AMsh glia; closed arrowhead, intestine. All data are based on three biological replicates. Scale bars, 10 μm (E, F, G, and J [left]), 50 μm (H, I, and J [right]).
Figure 2.nhr-45 and nhr-156 regulate induction of XMEs
(A) cyp-33C2∷GFP induction following P. brevicompactum exposure.
(B) cyp-33C2∷GFP induction in intestine and AMsh glia in RNAi-treated worms. ****p < 0.0001, ***p < 0.001 (t test). Note that p values cannot be calculated for the intestine because there is no variation between replicates.
(C) cyp-33C2∷GFP induction in intestine and AMsh glia. nhr-45 (tm1307), 1,545 bp deletion with 235 bp insertion; nhr-156 (tm1819), 553 bp deletion; nhr-156 (gk325307), Trp215 > amber. New alleles generated are as follows: nhr-45 (ns886) (14 bp deletion in exon1, generated by CRISPR); nhr-45 (ns887) (11 bp insertion in exon 1, generated by CRISPR); nhr-45 (ns889) (7 bp deletion in exon 1, generated by CRISPR); nhr-156 (ns865) (Gln29 > ochre, generated by EMS mutagenesis). ****p < 0.0001 (ANOVA compared with WT + P. brevicompactum).
(D) cyp-33C2∷GFP induction in intestine and AMsh glia. Intpro is elt-2p for intestinal rescue, AMsh gliapro is F16F9.3p for glial rescue. ****p < 0.0001 (ANOVA compared with nhr-45[ns889]).
(E) Basal expression of cyp-33C2∷GFP in the absence of P. brevicompactum. ****p < 0.0001 (ANOVA).
(F) Expression of nhr-45∷GFP with F16F9.3p∷dsRed (AMsh glia).
(G) Expression of nhr-156p∷GFP with mir-228p∷NLS-RFP (pan-glia). In (F) and (G), open arrow, AMsh glia; closed arrow, intestine.
(H) Heatmap of expression changes of the 18 P. brevicompactum-induced XMEs in nhr-45 partial loss-of-function mutant strain (nhr-45 [ns889]; nsIs910 [elt-2p∷nhr-45]). +, P. brevicompactum exposure;−, control samples not exposed. All data are based on three biological replicates. Error bars, SEM (B, C, D, and E). Scale bars, 10 μm (A, F [top], and G), 100 μm (F [bottom]).
Figure 3.P. brevicompactum exposure causes mitochondrial stress and is toxic for nhr-45 mutants with impaired XME induction
(A) Representative images of indicated strains grown for 2 days from L1 arrest with or without P. brevicompactum exposure. elt-2p∷mCherry is used as a marker to visualize animals.
(B and C) Scoring of developmental stages of indicated strains grown as in (A). (B) ****p < 0.0001 (L4 stage, ANOVA versus WT without P. brevicompactum). (C) ****p < 0.0001 (L4 stage, ANOVA versus nhr-45[ns889] + P. brevicompactum).
(D) hsp-6p∷GFP expression under the indicated conditions.
(E) Quantification of hsp-6p∷GFP fluorescence intensity in anterior intestine, normalized to WT without P. brevicompactum exposure. ***p < 0.001, *p < 0.05 (t test versus corresponding line without P. brevicompactum).
(F) Expression of cyp-33C2∷GFP following antimycin treatment. Open arrowhead, AMsh glia; closed arrowhead, intestine.
(G) Scoring of cyp-33C2∷GFP expression in intestine and AMsh glia following antimycin treatment. All data are based on three biological replicates. Error bars, SEM (B and C); SD (E and G). Scale bars, 100 μm (A), 10 μm (D and F).
Figure 4.Natural variations in nhr-156 underlie phenotypic diversity in AMsh glial transcriptional responses to microbes
(A) cyp-33C2∷GFP expression following S. marcescens Db10 exposure. Open arrow, AMsh glia.
(B) Scoring of cyp-33C2∷GFP induction in AMsh glia. ****p < 0.0001 (ANOVA versus WT + Db10).
(C) Schematic showing SNPs in the nhr-156 gene that cause amino acid changes.
(D) cyp-33C2∷GFP expression in AMsh glia following exposure to S. marcescens or P. brevicompactum in the indicated strains. syb2944, WT N2 background with the endogenous nhr-156 locus replaced with the Hawaiian version of the gene.
(E and F) Quantification of cyp-33C2∷GFP fluorescence in AMsh glia, normalized to WT for each condition. Genotypes in (F) refer to representative F2 recombinant lines that were generated by crossing cyp-33C2∷GFP from N2 into the indicated isolates. ****p < 0.0001, **p < 0.01 (ANOVA versus corresponding WT). All data are based on three biological replicates.
(G) A model for nhr-45 and nhr-156 contributions to micorbial responses in C. elegans. Error bars, SEM (B); SD (E and F). Scale bars, 10 μm (A and D).
KEY RESOURCES TABLE
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Bacterial and virus strains | ||
| CGC | OP50 | |
| S. | CGC | Db10 |
| Chemicals, peptides, and recombinant proteins | ||
| Antimycin A from | Sigma-Aldrich | A8674 |
| Deposited data | ||
| RNAseq raw data | This study | GEO: GSE183331 |
| Experimental models: Organisms/strains | ||
|
| ATCC | 9056 |
| This study | OS11850 | |
| This study | OS12256 | |
| CGC | GR2250 | |
| CGC | SRU1 | |
| CGC | RW11634 | |
| CGC | OH2204 | |
| This study | OS11501 | |
| This study | OS11503 | |
| CGC | VL484 | |
| This study | OS12194 | |
| This study | OS12363 | |
| This study | OS12386 | |
| This study | OS12364 | |
| This study | OS12387 | |
| This study | OS12366 | |
| This study | OS12385 | |
|
| NBRP | tm1819 |
| This study | OS12203 | |
|
| This study | OS12406 |
| This study | OS12751 | |
| This study | OS12199 | |
| This study | OS12752 | |
| This study | OS12873 | |
| This study | OS12607 | |
| This study | OS12608 | |
| This study | OS12609 | |
| This study | OS12610 | |
| This study | OS12611 | |
| This study | OS12612 | |
| This study | OS12338 | |
| This study | OS12340 | |
| This study | OS12341 | |
| This study | OS12903 | |
| This study | OS12094 | |
| This study | OS12095 | |
| This study | OS11879 | |
| This study | OS12050 | |
| This study | OS12051 | |
| This study | OS13492 | |
| This study | OS13109 | |
| This study | OS13110 | |
| This study | OS12342 | |
| This study | OS12307 | |
| CGC | SJ4100 | |
| This study | OS13183 | |
| This study | OS13345 | |
| CB4856 – | CGC | CB4856 |
| This study | OS13111 | |
| JU258 - | CGC | JU258 |
| This study | OS13112 | |
| ED3046 - | CGC | ED3046 |
| This study | OS13113 | |
| ED3049 - | CGC | ED3049 |
| This study | OS13114 | |
| JU1088 - | CGC | JU1088 |
| JU1171 - | CGC | JU1171 |
| Recombinant DNA | ||
| pSW81 { | This study | pSW81 |
| pSW74 { | This study | pSW74 |
| pSW124 { | This study | pSW124 |
| pSW110 { | This study | pSW110 |
| pSW118 { | This study | pSW118 |
| pSW121 { | This study | pSW121 |
| WRM0636C_B02 (pRedFlp-Hgr) (nhr-45 [15070]∷S0001_pR6K_Amp_2xTY1ce_EGFP_FRT_rpsl_neo_FRT_3x FlagdFRT∷unc-119-Nat) | TransgeneOme |